Abstract: An energy storage apparatus includes at least one battery rack having at least two battery packs; a container configured to accommodate the at least one battery rack; and an air conditioner provided with a coolant supply part, which includes at least two blowout units respectively having a nozzle with a discharge hole through which a coolant is discharged and configured to individually switch a discharge direction of the coolant, toward any, one of the at least two battery packs and individually increase or decrease a discharge amount of the coolant and a control unit configured to adjust the discharge direction and the discharge amount of the coolant of each of the at least two blowout units, and a coolant suction part configured to suck a heated coolant inside the container.

Abstract: A battery rack includes a plurality of battery modules including at least one battery cell and a module case configured to accommodate the at least one battery cell and including a fire extinguishing unit capable of supplying a fire extinguishing agent into the module case when thermal runaway or fire occurs in the at least one battery cell; a rack case configured to accommodate the plurality of battery modules; and a drainage guide unit provided to the rack case and configured to guide the fire extinguishing agent used when the thermal runaway or fire occurs to be drained.

Abstract: A battery rack includes a plurality of battery modules respectively having at least one battery cell, a rack case configured to accommodate the plurality of battery modules, and a separation bracket mounted at the rear of the rack case and configured to secure a predetermined separated space at the rear of the rack case.

Abstract: A battery rack with increased durability to prevent a rack case from being deformed or broken by external impacts during delivery. To achieve the above-described object, the battery rack includes a plurality of battery modules arranged in a first direction, at least one rack case including a plurality of rack frames configured to mount the plurality of battery modules, and at least one fixing frame including a body in the shape of a plate extending along the plurality of battery modules and a fixing portion formed on one surface of the body and configured to be attached and detached to/from each of the plurality of battery modules.

Abstract: A battery pack includes a plurality of battery modules respectively having at least one battery cell, a rack case configured to accommodate the plurality of battery modules, a fire distinguishing water supply unit disposed at the rear of the rack case and connected to the plurality of battery modules, and a bracket unit configured to cover the fire distinguishing water supply unit and disposed at the rear of the rack case.

Abstract: A method for preparing a conjugate of a physiologically active polypeptide and a non-peptide polymer by linking physiologically active polypeptide with non-peptide polymer through a covalent bond using an organic solvent is provided. A method for preparing a physiologically active polypeptide complex by linking the conjugate with a carrier is provided. The complex shows improved in vivo duration and stability of the physiologically active polypeptide. The method can prepare the conjugate at a lower production cost, and the resulting conjugate shows an extension of in vivo activity at a relatively high level and significantly increase in the blood half-life.

Abstract: Provided are a protein conjugate in which a physiologically active polypeptide is linked to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound serving as a linker, exhibiting an increased duration of physiological activity compared to natural forms and a preparation method therefor. Since an increase in serum half-life of the physiologically active polypeptide of the protein conjugate, in which the biocompatible material, the non-peptidyl polymer-coupled fatty acid derivative compound, and the physiologically active polypeptide are linked, is proved, the protein conjugate may be widely used in the field of protein drugs.

Abstract: Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.

Abstract: Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex prepared by the present invention may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.

Abstract: Provided are a protein conjugate in which a physiologically active polypeptide is linked to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound serving as a linker, exhibiting an increased duration of physiological activity compared to natural forms and a preparation method therefor. Since an increase in serum half-life of the physiologically active polypeptide of the protein conjugate, in which the biocompatible material, the non-peptidyl polymer-coupled fatty acid derivative compound, and the physiologically active polypeptide are linked, is proved, the protein conjugate may be widely used in the field of protein drugs.

Abstract: It is disclosed a method for preparing calteridol used as MRI contrast agents. It provides a method for preparing calteridol comprising: obtaining teridol represented by the following Formula 2 by reacting gadoteridol represented by the following Formula 1 with decomplexing agent; and obtaining calteridol represented by the following Formula 3 by reacting calcium ion with teridol represented by following Formula 2.

Abstract: Described is an electroluminescent device including an array substrate having a thin-film transistor formed thereon, an organic insulating layer formed on the array substrate having the thin-film transistor formed thereon, barriers disposed on the organic insulating layer, an anode formed on the organic insulating layer between the barriers to thus be electrically connected to the thin-film transistor and configured to cover at least a portion of the barriers, a light-emitting layer formed on the anode, and a cathode formed on the light-emitting layer, thus exhibiting superior emission efficiency and a wide viewing angle. A method of making or manufacturing the electroluminescent device is also described.

Abstract: A battery rack includes a rack case, and a first battery module assembly and a second battery module assembly respectively including a plurality of battery modules stacked along an upper and lower direction of the rack case, and, inside the rack case, the plurality of battery modules of the second battery module assembly are arranged such that upper and lower portions thereof are inverted based on the arrangement of the plurality of battery modules of the first battery module assembly.

Abstract: A composition including insulin and a triple agonist having activity with respect to all of a glucagon receptor, GLP-1 receptor, and GIP receptor is disclosed. A composite preparation including the composition is also disclosed.

Abstract: A deicing and snow melting device, for elevating the melting point of ice and snow, comprises of a plurality of pellets including an active ingredient. Each pellet of the plurality of pellets has at least an underside and a topside. The active ingredient is selected from the group consisting of chloride salts, organic compounds, alcohols or mixtures thereof. A base comprising a water-soluble sheet is joined to either one of the underside or topside of each pellet of the plurality of pellets.

Abstract: A fire spreading prevention method in an energy storage system (ESS) composed of a plurality of battery racks including an individual battery rack fire detection step of detecting whether a fire occurs for each of the plurality of battery racks and a battery rack forced discharge step of forcibly discharging at least some of the plurality of battery racks when a fire is detected in the individual battery rack fire detection step.

Abstract: Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.

Abstract: Disclosed is a method for producing calcobutrol used as an MRI contrast agent. The method comprises the steps of: obtaining butrol represented by chemical formula 2 in the specification by reacting a gadobutrol represented by chemical formula 1 in the specification and a decomplexing agent; and obtaining a calcobutrol represented by chemical Formula 3 in the specification by reacting butrol with calcium ions.

Abstract: Disclosed is a method for the preparation of a complex in which a physiologically active polypeptide is covalently bonded to an immunoglobulin constant region via a non-peptidyl linker. The method is characterized by the employment of a reducing agent, by which conventional problems of low production yield and modification of the polypeptide can be overcome. The physiologically active polypeptide-non-peptidyl polymer-immunoglobulin constant region complex can be produced with high purity and yield as well as at low cost. Thus, the method is industrially useful. Moreover, by exhibiting a prolonged action profile, the physiologically active polypeptide-non-peptidyl polymer-immunoglobulin constant region complex can be effectively used for developing long-acting formulations of physiologically active polypeptides which have improved drug compliance.

Abstract: A composition and method for safely and easily melting snow and ice is disclosed. The composition includes a pellet comprising an active ingredient; and a base comprising a water-soluble film-forming material, the pellet being attached to the base.